Grazyna Adamus Selected Research

Retinaldehyde (Retinal)

8/2023	Characterization of autoimmune eye disease in association with Down's syndrome.
5/2023	Characterization of autoimmune eye disease in association with Down's Syndrome.
1/2021	Importance of Autoimmune Responses in Progression of Retinal Degeneration Initiated by Gene Mutations.
1/2020	Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.
1/2020	Current Techniques to Accurately Measure Anti-retinal Autoantibodies.
1/2018	Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?
12/2017	Recovery of outer retinal laminations on optical coherence tomography after treatment of cancer associated retinopathy.
1/2017	Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.
5/2016	GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy.
3/2016	Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Grazyna Adamus Research Topics

Disease

20	Ocular Paraneoplastic Syndromes 01/2020 - 07/2002
19	Neoplasms (Cancer) 01/2020 - 06/2004
16	Retinal Degeneration 01/2021 - 11/2002
6	Uveitis 08/2023 - 03/2002
5	Retinal Diseases 01/2021 - 01/2011
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012 - 05/2002
4	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 08/2007
4	Inflammation (Inflammations) 01/2021 - 01/2010
4	Melanoma (Melanoma, Malignant) 01/2020 - 07/2002
4	Anterior Uveitis 06/2006 - 05/2002
3	Eye Diseases (Eye Disease) 08/2023 - 12/2014
3	Wounds and Injuries (Trauma) 12/2022 - 11/2020
3	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2020 - 01/2013
3	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 12/2014
2	Down Syndrome (Down's Syndrome) 08/2023 - 05/2023
2	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 08/2023 - 05/2023
2	Blindness (Hysterical Blindness) 01/2021 - 03/2003
2	Disease Progression 01/2018 - 01/2013
2	Macular Edema 12/2017 - 09/2010
2	Ganglion Cysts (Ganglion) 03/2016 - 09/2004
2	Optic Neuritis (Retrobulbar Neuritis) 08/2014 - 01/2012
2	Optic Nerve Diseases (Optic Neuropathy) 08/2012 - 09/2011
1	Burns 05/2021
1	Wound Infection (Wound Infections) 05/2021
1	Hyperphagia (Overeating) 03/2021
1	Proteinuria 03/2021
1	Periodontal Diseases (Periodontal Disease) 07/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Cataract (Cataracts) 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2015
1	Uveal melanoma 09/2015
1	Breast Neoplasms (Breast Cancer) 03/2015
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 02/2015

Drug/Important Bio-Agent (IBA)

31	Retinaldehyde (Retinal)IBA 08/2023 - 03/2003
28	AutoantibodiesIBA 01/2020 - 07/2002
15	AntibodiesIBA 08/2023 - 07/2002
10	Proteins (Proteins, Gene)FDA Link 05/2016 - 03/2002
10	RecoverinIBA 05/2016 - 03/2002
8	AntigensIBA 01/2020 - 03/2002
8	Phosphopyruvate Hydratase (Enolase)IBA 12/2017 - 04/2005
5	LigandsIBA 02/2013 - 06/2006
5	Myelin Basic ProteinIBA 06/2006 - 03/2002
4	EnzymesIBA 03/2021 - 03/2007
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2013 - 01/2010
3	CelluloseIBA 12/2022 - 11/2020
3	HydrogelsIBA 05/2021 - 07/2020
3	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2020 - 03/2016
3	Carbonic Anhydrase IIIBA 01/2016 - 03/2009
3	Peptides (Polypeptides)IBA 02/2013 - 01/2010
3	TransducinIBA 01/2010 - 07/2002
2	Transcription Factors (Transcription Factor)IBA 08/2023 - 05/2023
2	AIRE ProteinIBA 08/2023 - 05/2023
2	CyclodextrinsIBA 12/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2009
2	ArrestinIBA 01/2020 - 02/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2010
2	AutoantigensIBA 01/2017 - 09/2011
2	EpitopesIBA 01/2016 - 05/2002
2	CytokinesIBA 02/2013 - 01/2010
2	ChemokinesIBA 02/2013 - 01/2010
2	Chemokine CCL5IBA 02/2013 - 06/2002
2	interstitial retinol-binding proteinIBA 10/2011 - 01/2010
2	CaspasesIBA 09/2004 - 11/2002
1	thymoquinoneIBA 12/2022
1	Antifungal AgentsIBA 05/2021
1	Biopolymers (Biopolymer)IBA 05/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	SilverIBA 11/2020
1	Anti-Infective Agents (Microbicides)IBA 11/2020
1	CurcuminIBA 11/2020
1	Liposomes (Liposome)IBA 07/2020
1	PolymersIBA 07/2020
1	Therapeutic UsesIBA 07/2020
1	MicellesIBA 01/2019
1	AngiostatinsIBA 01/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	Angiogenesis InhibitorsIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	difluprednate FDA Link 12/2017
1	Pyruvate KinaseIBA 01/2017
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2017
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2015
1	binimetinibIBA 09/2015
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 08/2014
1	GelsIBA 09/2013
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2013
1	Interleukin-2 (IL2)IBA 02/2013
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 02/2013
1	Interleukin-6 (Interleukin 6)IBA 02/2013

Therapy/Procedure

6	Therapeutics 12/2017 - 03/2009
2	Drug Therapy (Chemotherapy) 05/2021 - 01/2019
2	Immunotherapy 02/2013 - 01/2012
1	Injections 01/2018
1	Plasma Exchange 01/2018
1	Aftercare (After-Treatment) 12/2017
1	Slit Lamp 09/2015
1	Transplantation 02/2015